About Smilax Laboratories Limited
Data last updated:
Smilax Laboratories Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2004PLC044461. Its GSTIN is 36AAJCS3390R1ZI (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹97 Cr and a paid-up capital of ₹96.04 Cr. It is led by directors including Suryadevara Murali Krishna (Managing Director) and Ramakrishna Reddy Munnamgi.
Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 12/A Phase III Ida Jeedimetla, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹206.57 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹3.41 Cr (net margin -1.7%) and EBITDA of ₹11.52 Cr (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The company has about 521 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Smilax Laboratories. As per MCA filings, the company has open charges of ₹11.51 Cr and satisfied charges of ₹465.93 Cr on record. Court records list 20 cases involving the company, including 5 filed by the company and 11 filed against it; 3 cases are pending. The company has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹138.99 Cr; the latest was in February 2019. Its 10 peer companies in the Pharma industry (API Manufacturers, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Aktinos Pharma Private Limited with revenue of ₹207.85 Cr. The company has 20 MSME Form 1 returns on record between 2019 and 2024, listing 466 overdue payments to 79 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smilaxlabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No 12/A Phase III Ida Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryPharma, Drug Formulation & Development, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Smilax Laboratories Limited
The main business activity of Smilax Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Smilax Laboratories Limited FY 2025 filings available
Smilax Laboratories Limited reported revenue of ₹206.57 Cr (down 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Smilax Laboratories Limited
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Smilax Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹206.57 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.52 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.41 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Smilax Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Smilax Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Smilax Laboratories Limited
Smilax Laboratories Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aktinos Pharma Private Limited | ₹207.85 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Hyderabad, Telangana, India |
| Ambalal Sarabhai Enterprises Limited Listed | ₹207.57 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
| Nifty Labs Private Limited | ₹206.98 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Aran Road, Ameerpet, Hyd-016, Telangana, India |
| Inogent Laboratories Private Limited | ₹206.9 Cr (FY 2017) | •••• | •••• | 18.0% | •••• | Hyderabad, Telangana, India |
| Cheryl Laboratories Pvt Ltd | ₹206.58 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Smilax Laboratories Limited this company | ₹206.57 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Hyderabad, Telangana, India |
| Swati Spentose Private Limited | ₹205.55 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Mumbai, Maharashtra, India |
| Sharon Bio-Medicine Limited Listed | ₹204.22 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Panvel, Maharashtra, India |
| Orch Laboratories India Private Limited | ₹203 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Radison Labs Private Limited | ₹202.11 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Hyderabad, Telangana, India |
| Topnotch Chemicals Pvt Ltd | ₹201.92 Cr (FY 2024) | •••• | •••• | -14.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Smilax Laboratories by revenue in the Pharma industry (API Manufacturers, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Smilax Laboratories Limited
Smilax Laboratories Limited is audited by A B V & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A B V & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Smilax Laboratories Limited
Smilax Laboratories has 4 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramakrishna Reddy Munnamgi Also directs: Everblooming Agritech Private Limited, Tridax Laboratories Limited, Ramky Life Sciences Limited and 5 more | Director | 25 Jun 2019 | 7 Years 3 Months | Current |
| Suryadevara Murali Krishna | Managing Director | 01 Mar 2010 | 16 Years 7 Months | Current |
| Surender Reddy Geedipalli Also directs: Ramky Viha Properties Private Limited, Ramky Srisairam Properties Private Limited, Ramky Estates and Farms Limited and 2 more | Director | 24 Sep 2021 | 5 Years 0 Months | Current |
| Saibaba Reddy Eadala Also directs: Ramky Viha Properties Private Limited, Ramky Srisairam Properties Private Limited, Ramky Estates and Farms Limited and 1 more | Director | 24 Sep 2021 | 5 Years 0 Months | Current |
Ownership and Shareholding of Smilax Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Smilax Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2006 | Bank of India | ₹11.51 Cr | Open |
| 28 Mar 2016 | Axis Bank Limited | ₹85 Cr | Satisfied |
| 31 Mar 2014 | Idfc Limited | ₹100 Cr | Satisfied |
| 24 Mar 2014 | Idfc Limited | ₹37.5 Cr | Satisfied |
| 29 May 2009 | Andhra Bank | ₹81.89 Cr | Satisfied |
Total charge records: 9 View all charges
Deals & Funding of Smilax Laboratories Limited
Smilax Laboratories Limited has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹138.99 Cr; the latest was in February 2019.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: Numen Growth Partners Private Limited Seller: Re Sustainability Iwm Solutions Limited , Mumbai Waste Management Limited |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: Numen Growth Partners Private Limited Seller: Re Sustainability Industrial Solutions Private Limited |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: Mumbai Waste Management Limited Seller: VVD Constructions Private Limited |
| Nov 2017 | Funding round | ₹49.62 Cr | Investors: Mumbai Waste Management Limited , Re Sustainability Iwm Solutions Limited |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: VVD Constructions Private Limited Seller: an individual |
Full deal history
All 10 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Smilax Laboratories Limited
Smilax Laboratories Limited has 20 court cases on record: 5 filed by Smilax Laboratories, 11 filed against it, 4 where it is another party. 3 cases are pending and 17 are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 11 | 2 |
| High courts | 4 | 0 | 1 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against K.R.R. Drugs & Intermediates Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against Lancer Life Sciences Private Limited | Disposed |
| District court, Jaipur District, Rajasthan | Civil miscellaneous application | Filed against the company by Smilex Pharmaceuticals | Pending |
| High Court for State of Telangana | Court case (WP(PIL)) | Company is another party | Pending |
| District court, Medchal Malkajgiri, Telangana | Execution petition | Filed against the company by an individual | Pending |
Full case history
All 20 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Smilax Laboratories Limited
Smilax Laboratories Limited has 20 MSME Form 1 returns on record between 2019 and 2024, listing 466 overdue payments to 79 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 79)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Ladder Fine Chemicals | •••• | •••• | •••• |
| Sri Bhargavi Ammonia & Chemicals Private Limited | •••• | •••• | •••• |
| Bharat Science Apparatus Workshops | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 20 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Smilax Laboratories Limited
Smilax Laboratories operates one associated brand: Smilax Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs, intermediates, and pellets are manufactured by Smilax Laboratories. | smilaxlabs.com |
Employees and EPFO Compliance at Smilax Laboratories Limited
Smilax Laboratories Limited has a workforce of 521 employees as of Sep 26, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Smilax Laboratories Limited
Smilax Laboratories has one previous CIN (Corporate Identification Number): U24230AP2004PLC044461. The current CIN is U24230TG2004PLC044461, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2004PLC044461 | Current |
| U24230AP2004PLC044461 | Previous |
Recent Activity on Smilax Laboratories Limited
Smilax Laboratories Limited has 18 board changes on record since 2007: 5 appointments and 13 cessations. The latest: Pulicherla Ganesh was appointed as CFO on 15 Nov 2021.
31 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Smilax Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Smilax Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Smilax Laboratories Limited
Smilax Laboratories has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCS3390R1ZI | Telangana | Active | 01 Jul 2017 |
| 36AAJCS3390R2ZH | Telangana | Active | 21 Aug 2017 |
| 37AAJCS3390R1ZG | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Smilax Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Smilax Laboratories Limited
Smilax Laboratories is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 October 2004 (22+ years old) and is registered under CIN U24230TG2004PLC044461.
Smilax Laboratories reported revenue of ₹206.57 Cr for FY 2025 (down 25% YoY).
Smilax Laboratories has 4 current directors:
- Suryadevara Murali Krishna - Managing Director
- Ramakrishna Reddy Munnamgi - Director
- Surender Reddy Geedipalli - Director
- Saibaba Reddy Eadala - Director
Smilax Laboratories reported a net loss of ₹3.41 Cr (net margin -1.7%) and EBITDA of ₹11.52 Cr (EBITDA margin 5.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Smilax Laboratories is 1% over three years and 1% over five years. In the latest year (FY 2025) revenue fell 25%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Smilax Laboratories is 36AAJCS3390R1ZI, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AAJCS3390R2ZH (Telangana), 37AAJCS3390R1ZG (Andhra Pradesh).
The CIN (Corporate Identification Number) of Smilax Laboratories is U24230TG2004PLC044461. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smilax Laboratories has 20 court cases on record: 5 filed by the company and 11 filed against it. 3 are pending. Most are in the district courts.
Smilax Laboratories was incorporated on 20 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Smilax Laboratories has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹138.99 Cr; the latest was in February 2019.
The peers of Smilax Laboratories by revenue are Aktinos Pharma Private Limited, Ambalal Sarabhai Enterprises Limited, Nifty Labs Private Limited, Inogent Laboratories Private Limited, Cheryl Laboratories Pvt Ltd and 5 more, all in the Pharma industry (API Manufacturers, Formulations).
Pulicherla Ganesh was appointed as CFO on 15 Nov 2021. Saibaba Reddy Eadala ceased to be Additional Director on 20 Oct 2021. Surender Reddy Geedipalli ceased to be Additional Director on 20 Oct 2021. Smilax Laboratories has 18 board changes on record in total.